TITLE

Acceso universal al Programa de VIH/SIDA de la Ciudad de México: resultados a seis años

AUTHOR(S)
Claudín, Carmen Soler
PUB. DATE
January 2009
SOURCE
Salud Pública de México;ene/feb2009, Vol. 51 Issue 1, p26
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Objective. To analyze the results of the Free Antiretroviral Medication Program of the Mexico City HIV/AIDS Program among the affected population in Mexico City. Material and Methods. A retrospective analysis was conducted of medical attention, antiretroviral treatment and specialized laboratory results data from 2001 to 2006 from patients who sought services from the Mexico City HIV/AIDS Program. Results. Data from 5 146 patients who were undergoing ARV are presented. At the end of the period studied, 74% were current, 12.2% were not found for follow-up and 13.9% had died. Conclusions. During the period evaluated, wider coverage was achieved in Mexico City as well as increased efficiency in ARV treatment and increased patient survival.
ACCESSION #
36116244

 

Related Articles

  • A Victory--And a New War. Achmat, Zackie // Newsweek (Pacific Edition);04/30/2001 (Pacific Edition), Vol. 137 Issue 18, p19 

    Presents an account of the author's experience as a gay man with HIV involved with anti-apartheid work in Africa. Importance of the lawsuit on HIV/AIDS drugs dropped by pharmaceutical companies; Cost of anti-retroviral medication for patients with HIV/AIDS; Challenge to transform the victory...

  • A Victory--And a New War. Achmat, Zackie // Newsweek (Atlantic Edition);04/30/2001 (Atlantic Edition), Vol. 137 Issue 18, p23 

    Presents an account of the author's experience as a gay man with HIV involved with anti-apartheid work in Africa. Importance of the lawsuit on HIV/AIDS drugs dropped by pharmaceutical companies; Cost of anti-retroviral medication for patients with HIV/AIDS; Challenge to transform the victory...

  • Updated HIV Treatment Recommendations for 2002.  // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2159 

    Discusses the study 'Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel,' by P.G. Yeni et al., from the July 10, 2002 issue of the 'Journal of American Medical Association.'

  • Caring for the children. Cross, Robyn; Warriner, Jason // Nursing Standard;7/19/2006, Vol. 20 Issue 45, p23 

    KwaZulu Natal has the highest rates of HIV/AIDS in South Africa. Teams of British nurses and doctors visit the province regularly to help staff there learn about antiretroviral therapy.

  • Strengthening adherence to Anti Retroviral Therapy (ART) monitoring and support: operation research to identify barriers and facilitators in Nepal. Bam, Kiran; Rajbhandari, Rajesh M.; Karmacharya, Dibesh B.; Dixit, Sameer M. // BMC Health Services Research;2015, Vol. 15 Issue 1, p1 

    Background: Anti Retroviral Therapy (ART) is the cornerstone for comprehensive health sector response to Human Immunodeficiency Virus (HIV) treatment, care and support. Adherence of at least 95% is needed to keep HIV under control, as per World Health Organization (WHO) guidelines. This study...

  • CLINICAL CARE OF MEN LIVING WITH HIV/AIDS, WHO HAVE SEX WITH WOMEN, IN SÃO PAULO, BRAZIL. Segurado, A.; Nascimento, V.; Batistela, E.; Braga, P.; Bosco, S.; Elvira, F.; Naila, S.; Vera, P. // Journal of Epidemiology & Community Health;Aug2004 Supplement 1, Vol. 58, pA117 

    The article presents study related to clinical care of men with HIV/AIDS. The core of people living with HIV/AIDS in Brazil, following guidelines issued by National Ministry of Health, has brought about a significant reduction in the morbidity and mortality associated with this retroviral...

  • Recent Developments in Antiretroviral Therapy. DeSimone, Gary A. // Clinical Journal of Oncology Nursing;Nov/Dec2001, Vol. 5 Issue 6, p1 

    This article reviews the antiretroviral medications in development as presented at the 8th Annual Conference on Retroviruses and Opportunistic Infections. New medications for the treatment of HIV/AIDS are discussed by classification and a brief description of its unique quality is described.

  • HIV/AIDS 2001: Latest treatment strategies. Brown, Billy Ray; Robinson, Marvin // Drug Topics;3/19/2001, Vol. 145 Issue 6, p39 

    Presents updates on the development of treatment strategies for AIDS/HIV in 2001. Classes of antiretrovirals approved by the United States Food and Drug Administration; Study which determined the role of adherence to virologic failures in the majority of patients; Lipid management in HIV.

  • Treatment-Mediated Changes in Human Immunodeficiency Virus (HIV) Type 1 RNA and CD4 Cell Counts... Lindsey, Jane C.; Hughes, Michael D.; McKinney, Ross E.; Cowles, Mary K.; England, Janet A.; Baker, Carol J.; Burchett, Sandra K.; Kline, Mark W.; Kovacs, Andrea; Moye, Jack // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1385 

    Evaluates the predictive value of antiretroviral treatment-mediated changes in 3 markers of human immunodeficiency virus type 1 disease progression. HIV-1 RNA level; CD4 cell count; CD4 percentage; Weight growth failure; Cognitive decline; Survival of HIV-infected children; Differential age...

  • Antiretroviral Therapy in AIDS. Broder, Samuel; Mitsuya, Hiroaki; Yarchoam, Robert; Pavlakis, George N. // Annals of Internal Medicine;10/15/90, Vol. 113 Issue 8, p604 

    Discusses the development of antiretroviral therapy for AIDS and related disorders. Summary of a Clinical Staff Conference on October 26, 1988 at the National Institutes of Health; Emergence of drug-resistant virus variants; Description of the activity of 2', 3'-dideoxynucleosides against other...

Share

Other Topics